Short answer
Entrada Therapeutics, Inc. (TRDA) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Item 2.02 references Entrada’s August 5, 2026 earnings press release.
Entrada Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 references Entrada’s August 5, 2026 earnings press release
- Financial results and management commentary appear in Exhibit 99.1
- Investors should review Exhibit 99.1 for fiscal-year performance and guidance details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Entrada Therapeutics, Inc. 8-K filings
Get the next TRDA 8-K as it lands
Follow TRDA for push alerts, or ask the research agent what this filing means.